[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100340139":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":34,"responsibleParty":54,"collaborators":18,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":18,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":18,"enrollmentInfo":65,"targetDuration":18,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":18,"overallStatus":37,"whyStopped":18,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"Johns Hopkins University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Bimatoprost in more proptotic eye","EXPERIMENTAL","Patients instill Bimatoprost in their more proptotic eye one nightly",[13],"Drug: Bimatoprost Ophthalmic",{"label":15,"type":16,"description":17,"interventionNames":18},"Control","NO_INTERVENTION","Bimatoprost is not instilled in the patient's fellow eye",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"DRUG","Bimatoprost Ophthalmic","Bimatoprost, aka Lumigan, one drop in one eye nightly",[9],[26],{"name":27,"affiliation":5,"role":28},"Emily Li, MD","PRINCIPAL_INVESTIGATOR",[30],{"name":27,"role":31,"phone":32,"phoneExt":18,"email":33},"CONTACT","410-955-1112","eli20@jhmi.edu",[35],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"University of Washington","RECRUITING","Seattle","Washington","98104","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-122.33207,47.60621,{"lat":47,"lon":46},[50],{"name":51,"role":31,"phone":52,"phoneExt":18,"email":53},"Alexandra Van Brummen, MD","206-543-7250","avanbrum@uw.edu",{"type":55,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100340139","early-phase-1-bimatoprost-as-a-treatment-for-graves-orbitopathy-100340139",false,"NCT03708627","Bimatoprost as a Treatment for Graves' Orbitopathy","The Role of Bimatoprost in Graves' Periorbitopathy","Inclusion Criteria: Graves' Ophthalmopathy with Exophthalmos\u002FProptosis -\n\nExclusion Criteria: Active Graves Disease, Currently pregnant, Taking Steroids\n\n\\-","ALL","18 Years",{"count":66,"type":67},3,"ESTIMATED","INTERVENTIONAL",[70],"EARLY_PHASE1","Testing whether Bimatoprost, a topical eye drop used for glaucoma, can be used to induce periorbital fat atrophy in patients with Graves' disease",[73],"Graves Ophthalmopathy","2025-07-14",{"date":76,"type":77},"2025-07-17","ACTUAL",{"date":79,"type":77},"2017-11-01",{"date":81,"type":67},"2031-07-01",{"name":5,"class":6},1]